Interclass drug effects and changes in regional brain glucose metabolism

Psychopharmacology Bulletin

Volumn 34, Issue 2, 1998, Pages 229-232

  Cooper, Malcolm ^a   Metz, J ^b   de Wit, H ^b   Cook, E ^b   Lorenz, J ^b   Brown, T ^b  

^a Franklin McLean Memorial Research Institute   (United States)

^b NONE

Author keywords

Cerebral metabolism; Fluoxetine; Nimodipine; Pimozide

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; BRAIN METABOLISM; BRAIN REGION; DRUG EFFECT; DRUG EFFICACY; GLUCOSE BRAIN LEVEL; HUMAN; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

BRAIN; BRAIN CHEMISTRY; GLUCOSE; HUMANS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031842363     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Cook, EH; Metz, J; Leventhal, BL; Lebovitz, M; Nathan, M; Semerdjian, SA; Brown, T; and Cooper, MD. Fluoxetine effects on cerebral glucose metabolism. NeuroReport 5:1745-1748, 1994.
2. Drevets, WC; Price, JL; Simpson, JR; Todd, RD; Reich, T; Vannier, M; and Raichle, ME. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386:824-827, 1997.
3. 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Arch. Gen. Psychiatry 49:538-544, 1992.
4. Friston, KJ; Frith, CD; Liddle, PF; and Frackowiak, RSJ. Comparing functional (PET) images: The assessment of significant change. J. Cereb. Blood Flow Metab. 11:690-699, 1991.
5. Lorenz, JM; Metz, J; Singh, J; Kronmal, S; and Cooper, MD. Acute effect of nimodipine on regional cerebral metabolic rate of glucose (rCRglu) on elderly normal subjects. Soc. Neurosci. Abstr. 19:895, 1993.